Skip to main content
Log in

Efficacy Profiles of Psychopharmacology: Divalproex Sodium in Conduct Disorder

  • Original Paperr
  • Published:
Child Psychiatry and Human Development Aims and scope Submit manuscript

Abstract

Little is known about how deeply medication treatment penetrates different levels of the mind/brain system. Psychopathology consists of relatively simple constructs (e.g., anger, irritability), or complex ones (e.g., responsibility). This study examines the efficacy of a specific compound, divalproex sodium (DVPX), on the various levels of psychopathology, utilizing a previous study in which 71 youth with conduct disorder were enrolled in a randomized controlled 7-week clinical trial. We examined weekly slopes of “emotional cognitions” of varying degrees of complexity obtained by Weinberger Adjustment Inventory (WAI), measuring more basic states, such as anger, depression, happiness and anxiety, and complex states, such as impulse control, consideration of others, responsibility and self-esteem. Intent-to-treat analyses showed significant associations between assignment to the active treatment and improvement in depression and impulse control. This is a rare clinical trial, which provides preliminary evidence for the different profiles of efficacy of medication treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chang K, Simeonova D (2004) Mood stabilizers: use in pediatric psychopharmacology. In: Steiner H (ed) Handbook of mental health interventions in children and adolescents. Jossey Bass, SFO CA

    Google Scholar 

  2. DiMascio A, Weissman MM, Prusoff BA (1979) Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 36(13):145–146

    Google Scholar 

  3. Rush AJ, Beck AT, Kovacs M (1982) Comparison of the effects of cognitive therapy pharmacotherapy on hopelessness and self-concept. Am J Psychiatry 139(7):862–866

    PubMed  Google Scholar 

  4. Puig-Antich JP, Perel JM, Chambers WJ (1980) Imipramine treatment of prepubertal major depressive disorders: plasma levels and clinical response—preliminary report. Psychopharmacol Bull 16(1):25–27

    PubMed  Google Scholar 

  5. Kosten JB, Frank E, Dan CJ (1991) Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 179:366–370

    Article  PubMed  Google Scholar 

  6. FDA Warning: Possible Suicide, severe depression, anxiety, panic attacks in children and adolescents take any of the 10 popular antidepressants, especially at the beginning of the treatment or when the doses are increased or decreased

  7. Steiner H, Khanzode L, King M, Mordecai D (2004) Integrating treatment: a developmental perspective. In: Steiner H (ed) Handbook of mental health interventions in children and adolescents. Jossey Bass, SFO CA

    Google Scholar 

  8. Kandel E (1998) A new intellectual framework for psychiatry. Am J Psychiatry 155: 457–469

    PubMed  Google Scholar 

  9. Gabbard GO, Kay J (2001) The fate of integrated treatment: whatever happened to the biopsychosocial psychiatrist?. Am J Psychiatry 158(12):1956–1963

    Article  PubMed  Google Scholar 

  10. Searle J (2002) Consciousness and language. Cambridge University Press, NY, pp 18–35

    Google Scholar 

  11. Ekman P (1984) Expression and the nature of emotion. In: Scherer K, Ekman P (eds) Approaches to emotion. Erlbaum, Hillsdale NJ

    Google Scholar 

  12. Ekman P (1993) Facial expression and emotion. Am Psychol 48(4):384–392

    Article  PubMed  Google Scholar 

  13. Steiner H, Petersen M, Saxena K (2003) Divalproex sodium for the treatment of severe conduct disorder: a randomized controlled clinical trial. J Clin Psychiatry 64:1183–1191

    Article  PubMed  Google Scholar 

  14. Hollander E, Posner N, Cherkasy S (2002) Neropyschiatric aspects of aggression and impulse control disorders. In: Yudfshy SC, Hales RE (eds) American psychiatric press textbook of Neuropsychiatry. American Psychiatric press, Washington DC, pp 579–596

    Google Scholar 

  15. Weinberger DA (1997) Distress and self-restraint as measures of adjustment across the life span: confirmatory factor analysis in clinical and non-clinical samples. Psychol Assess 9(2):132–135

    Article  Google Scholar 

  16. Grissom RJ (1994) Probability of superior outcome of one treatment over another. J Appl Psychol 79(2):314–316

    Article  Google Scholar 

  17. Kraemer HC, Morgan GA, Leech NL, Gilner JA,Vaske JJ, Harmon RJ (2003) Measures of clinical significance. J Am Acad Child Adolesc Psychiatry 42(12):1524–1529

    Article  PubMed  Google Scholar 

  18. Petty F, Kram M, Davis LL (1999) Valproate treatment of bipolar depression. Proceeding of 39th Annual NCDEU Meeting. Boca Raton FL: 70

  19. Winsberg ME, DeGolia SG, Strong CM, Ketter TA (2001) Divalproex therapy in medication-naïve and mood stabilizer-naïve bipolar II depression. J Affect Disord 67:207–212

    Article  PubMed  Google Scholar 

  20. Takebayashi M, Motohashi N, Saito H, Kagaya A, Yamawaki S (1995) Effect of acute treatment with sodium valproate on catecholamine and serotonin synthesis in mouse cerebral cortex. Neuropsychobiology 32:124–127

    Article  PubMed  Google Scholar 

  21. Linnoila M, Virkkunen M, Scheinin M (1983) Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 33(26):2609–2614

    Article  PubMed  Google Scholar 

  22. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD (2002) Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology 26(4):530–536

    Article  PubMed  Google Scholar 

  23. Donovan SJ, Stewart JW, Nunes EV (2000) Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry 157:818–820

    Article  PubMed  Google Scholar 

  24. Hollander E, Allen A, Lopez RP (2001) A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry 62(3):199–203

    Article  PubMed  Google Scholar 

  25. Hollander E, Tracy KA, Swann AC (2003) Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 28(6):1186–1197

    PubMed  Google Scholar 

  26. Hollander E, Swann A, Coccaro EF Divalproex sodium is superior to placebo for impulsive aggression in cluster B personality disorders. Abstract: 155th Annual Meeting of the American Psychiatric Association (APA); May 18–23, 2002; Philadelphia, PA

  27. Hollander E, Evers M (2001) New developments in impulsivity. Lancet 358:949–950

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leena A. Khanzode.

Additional information

This research was supported by grants to Dr. Steiner by Abbott Pharmaceuticals, The California Wellness Foundation and by the California Youth Authority.

Appendix A

Appendix A

Questionnaire

Classifying Emotions

Here is a list of some emotional states, please help us categorize them into “Primary/Basic” and “Secondary/ Complex” emotions, if you can not decide please put a “?” in front of it. Put P for Primary and S for secondary/complex.

To help you do this lets go through the definitions of primary/basic and secondary/complex emotions.

According to Paul Ekman, primary/basic emotions are the emotions, which have evidence of universality in spontaneous expressions and in expressions that are deliberately posed and secondary/complex emotions are blends or mixes of the basic emotions.

Table 1

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khanzode, L.A., Saxena, K., Kraemer, H. et al. Efficacy Profiles of Psychopharmacology: Divalproex Sodium in Conduct Disorder. Child Psychiatry Hum Dev 37, 55–64 (2006). https://doi.org/10.1007/s10578-006-0019-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10578-006-0019-4

Keywords

Navigation